This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of other and unspecified digestive organs
CD2_INSITU_DIGESTIVE_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ organorum digestoriorum aliorum sive non specificatorum
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of other and unspecified digestive organs
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of other and unspecified digestive organs
- In situ neoplasms
- In situ neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 831 | 350 | 481 |
| Unadjusted period prevalence (%) | 0.17 | 0.12 | 0.21 |
| Median age at first event (years) | 69.88 | 69.02 | 70.50 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 745
- Matched controls
- 7451
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
17.2
166.7
285
259
UJF32
NOMESCO Finland
Coloscopy
8.4
152.5
465
1223
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
27.6
150.1
211
105
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
125.6
117
*
130
Kela drug reimbursment
Malignant tumour
+∞
124.5
116
*
8263/2-C20.9
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS
+∞
99.2
93
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
98.1
92
*
WX402
NOMESCO Finland
General anaesthesia
7.8
97.0
255
463
WX302
NOMESCO Finland
Thoracal epidural anesthesy
25.2
95.8
137
66
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
93.7
88
*
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
12.4
92.2
177
183
L01BC06
ATC
capecitabine; oral
+∞
75.3
71
*
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
163.9
71.4
74
5
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
10.0
71.1
151
184
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
71.0
67
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
375.5
69.8
69
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
11.6
69.3
135
139
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
13.0
69.0
127
116
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
16.0
65.3
109
79
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
15.3
61.3
104
78
C209, 8211, 2
ICD-O-3
NA
+∞
59.1
56
*
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
21.1
58.7
88
47
B01AB05
ATC
enoxaparin; parenteral
3.7
55.8
338
1372
H02AB02
ATC
dexamethasone; systemic
27.6
54.5
75
30
A04AA02
ATC
granisetron; systemic, transdermal
555.4
53.2
52
*
C209, 8148, 2
ICD-O-3
NA
+∞
51.7
49
*
JN4BD
NOMESCO Finland
Extensive body CT
8.4
51.6
120
166
WF002
NOMESCO Finland
Radical radiotherapy
189.7
51.6
53
*
JN4AD
NOMESCO Finland
Body CT examination
9.1
48.2
106
133
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
33.1
46.6
61
20
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
48.3
44.8
54
12
8263/2-C18.0
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of cecum
+∞
44.2
42
*
D01.0
ICD-10 Finland
Carcinoma in situ: Colon
+∞
43.1
41
*
C187, 8211, 2
ICD-O-3
NA
+∞
42.1
40
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
39.9
38
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.6
39.0
149
382
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
38.9
37
*
116
Kela drug reimbursment
Prostate cancer
+∞
38.9
37
*
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
11.8
37.7
71
66
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
17.1
37.5
60
38
JFF23
NOMESCO Finland
Transversostomy
86.7
37.2
41
5
B01AB10
ATC
tinzaparin; parenteral
7.0
37.0
96
154
D01.2
ICD-10 Finland
Carcinoma in situ: Rectum
+∞
36.8
35
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.4
36.4
145
386
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
374.4
36.3
36
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
34.6
33
*
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
122.2
32.9
35
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
32.5
31
*
WZC30
NOMESCO Finland
Teaching
4.3
31.5
128
344
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
+∞
31.5
30
*
8263/2-C18.7
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of sigmoid colon
+∞
31.5
30
*
C189, 8211, 2
ICD-O-3
NA
+∞
31.5
30
*
K63.5
ICD-10 Finland
Polyp of colon
15.4
31.4
52
36
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
325.7
31.1
31
*
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
12.8
30.7
55
46
WX600
NOMESCO Finland
Single shot through catheter
39.9
30.5
38
10
XX3DW
NOMESCO Finland
Time consuming IT work
6.2
30.5
86
154
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
30.4
29
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
111.2
29.9
32
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
29.4
28
*
R4110
NOMESCO Finland
Physiotherapy
2.7
29.0
248
1153
L02AE02
ATC
leuprorelin; implant, parenteral
107.6
28.9
31
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
80.8
28.0
31
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
80.8
28.0
31
*
PJA12
NOMESCO Finland
Sentinel node biopsy
145.2
26.8
28
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
26.4
240
1143
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
+∞
26.2
25
*
C180, 8211, 2
ICD-O-3
NA
+∞
26.2
25
*
JG1CG
NOMESCO Finland
Extensive MRI of rectum
96.8
25.8
28
*
UJF30
NOMESCO Finland
Ileoscopy through colon
3.9
25.7
116
340
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
25.1
24
*
8263/2-C18.9
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of colon, NOS
+∞
25.1
24
*
JGA73
NOMESCO Finland
Transanal excision of lesion of rectum
72.4
25.0
28
*
UJF32
SPAT
NA
11.3
24.4
46
43
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
24.1
23
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
23.0
22
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
23.0
22
*
Z51.5
ICD-10 Finland
Palliative care
8.6
22.8
50
62
A04AA01
ATC
ondansetron; systemic, rectal
8.9
22.4
48
57
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
53.7
22.2
26
5
115
Kela drug reimbursment
Breast cancer
+∞
22.0
21
*
JFB30
NOMESCO Finland
Right hemicolectomy
27.3
21.5
29
11
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
20.9
264
1455
C187, 8148, 2
ICD-O-3
NA
+∞
20.9
20
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
20.9
20
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
20.9
20
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
20.9
20
*
JG1BG
NOMESCO Finland
MRI of rectum
79.1
20.8
23
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
4.9
20.6
69
151
UJG02
NOMESCO Finland
Proctoscopy
8.9
20.1
43
51
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
20.0
196
952
WF049
NOMESCO Finland
Radiotherapy of metastasis
107.9
19.6
21
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
19.3
204
1027
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
18.8
18
*
C189, 8148, 2
ICD-O-3
NA
+∞
18.8
18
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
18.8
18
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
18.8
18
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
71.7
18.8
21
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
18.5
286
1705
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
17.8
17
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
17.8
17
*
JGA75
NOMESCO Finland
Endoscopic microsurgical excision of lesion of rectum
+∞
17.8
17
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
17.8
17
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
17.7
154
695
D75
ICPC
Malignant neoplasm colon/rectum
97.3
17.6
19
*
TJF80
NOMESCO Finland
Ostomy education
29.6
17.5
23
8
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
16.7
16
*
8211/2-C18.2
ICD-O-3
Tubular adenocarcinoma in situ of ascending colon
+∞
16.7
16
*
C180, 8148, 2
ICD-O-3
NA
+∞
16.7
16
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
16.7
16
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
16.6
68
182
JGA85
NOMESCO Finland
Endoscopic mucosal or submucosal resection in rectum
173.6
16.6
17
*
N02BE01
ATC
paracetamol; systemic, rectal
2.3
16.4
639
5376
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.4
16.3
43
71
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.7
16.3
47
87
JFA15
SPAT
NA
19.0
16.1
24
13
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
15.7
15
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
15.7
15
*
Y77
ICPC
Malignant neoplasm prostate
+∞
15.7
15
*
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
+∞
15.7
15
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
15.7
15
*
ZXC96
NOMESCO Finland
Robot assisted procedure
16.5
15.3
24
15
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.2
15.1
177
924
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
14.9
125
552
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
+∞
14.6
14
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
14.6
14
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
14.6
14
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
14.6
14
*
8263/2-C18.2
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of ascending colon
+∞
14.6
14
*
C21.0
ICD-10 Finland
Malignant neoplasm: Anus, unspecified
+∞
14.6
14
*
L02BB03
ATC
bicalutamide; oral
+∞
14.6
14
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
14.6
14
*
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
81.7
14.6
16
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
14.5
96
368
D12.7
ICD-10 Finland
Benign neoplasm: Rectosigmoid junction
12.3
14.2
25
21
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
54.4
13.8
16
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
13.7
115
503
Z71.8
ICD-10 Finland
Other specified counselling
2.1
13.7
177
959
D12.9
ICD-10 Finland
Benign neoplasm: Anus and anal canal
15.1
13.6
22
15
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
76.5
13.6
15
*
8140/2-C20.9
ICD-O-3
Adenocarcinoma in situ, NOS, of rectum, NOS
+∞
13.6
13
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
13.6
13
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
13.6
13
*
C21.1
ICD-10 Finland
Malignant neoplasm: Anal canal
+∞
13.6
13
*
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
+∞
13.6
13
*
JFA52
NOMESCO Finland
Other endoscopic haemostatic procedure in colon
26.3
13.4
18
7
A02BC02
ATC
pantoprazole; systemic
1.8
13.3
476
3681
Z3231
NOMESCO Finland
Registered nurse
2.0
12.8
212
1260
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
71.1
12.6
14
*
L03AA02
ATC
filgrastim; parenteral
71.1
12.6
14
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
12.5
12
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
12.5
12
*
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
+∞
12.5
12
*
C209, 8213, 2
ICD-O-3
NA
+∞
12.5
12
*
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
38.2
12.2
15
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.0
12.2
71
251
K62.1
ICD-10 Finland
Rectal polyp
8.4
12.1
26
32
Z93.3
ICD-10 Finland
Colostomy status
21.7
12.0
17
8
TQW40
NOMESCO Finland
Remowal of suture of skin
3.1
11.8
67
232
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.1
11.8
46
119
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
66.0
11.6
13
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
66.0
11.6
13
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
11.5
11
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
11.5
11
*
8140/2-C18.7
ICD-O-3
Adenocarcinoma in situ, NOS, of sigmoid colon
+∞
11.5
11
*
JN4CD
NOMESCO Finland
Very extensive body CT
5.9
11.4
31
54
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
11.2
279
1888
ZXE00
NOMESCO Finland
One hour or less
1.8
11.2
279
1889
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
44.0
10.9
13
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.8
10.8
68
254
JFF10
NOMESCO Finland
Loop enterostomy
21.8
10.7
15
7
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
10.5
233
1515
D18
ICPC
Change in faeces/bowel movements
6.0
10.5
28
48
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
111.5
10.4
11
*
C188, 8211, 2
ICD-O-3
NA
+∞
10.4
10
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
10.4
10
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
10.4
10
*
D01.1
ICD-10 Finland
Carcinoma in situ: Rectosigmoid junction
+∞
10.4
10
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
10.4
10
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
10.4
10
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
10.4
10
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
10.4
10
*
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
+∞
10.4
10
*
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
+∞
10.4
10
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
10.4
335
2436
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
12.3
10.4
18
15
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.2
10.4
38
93
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.7
10.4
44
123
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
33.0
10.4
13
*
R4190
NOMESCO Finland
Nutritional therapy
5.9
10.3
28
49
WX002
NOMESCO Finland
Sedation and analgesia
1.9
10.3
163
942
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
9.7
10.3
20
21
WX110
NOMESCO Finland
Local anesthesy
1.7
9.9
452
3594
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.2
9.8
23
33
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.6
9.7
69
278
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
4.1
9.6
36
90
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
9.6
68
272
A79
ICPC
Malignancy NOS
101.2
9.4
10
*
L02BG04
ATC
letrozole; oral
17.8
9.4
14
8
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
9.4
9
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
9.4
9
*
D01.3
ICD-10 Finland
Carcinoma in situ: Anus and anal canal
+∞
9.4
9
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
9.4
9
*
C186, 8211, 2
ICD-O-3
NA
+∞
9.4
9
*
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
+∞
9.4
9
*
C184, 8148, 2
ICD-O-3
NA
+∞
9.4
9
*
C184, 8211, 2
ICD-O-3
NA
+∞
9.4
9
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
+∞
9.4
9
*
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
22.0
9.4
13
6
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
9.7
9.3
18
19
D12
ICD-10 Finland
Benign neoplasm of colon, rectum, anus and anal canal
15.8
9.1
14
9
N02AA05
ATC
oxycodone; systemic
2.2
8.9
97
484
R18
ICD-10 Finland
Ascites
8.7
8.8
18
21
Z2221
NOMESCO Finland
Medical doctor
1.7
8.8
197
1276
JFB21
NOMESCO Finland
Laparoscopic ileocaecal resection
50.6
8.7
10
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.3
8.7
25
48
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
8.7
88
422
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.2
8.5
43
139
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
91.0
8.4
9
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
8.3
8
*
C182, 8148, 2
ICD-O-3
NA
+∞
8.3
8
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
8.3
8
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
8.3
8
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
8.3
8
*
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
+∞
8.3
8
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
8.3
8
*
C18.02
ICD-10 Finland
Malignant tumor of caecum carcinoma of adenoma
+∞
8.3
8
*
JFB47
NOMESCO Finland
Laparoscopic resection of sigmoid colon
8.7
8.3
17
20
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.5
8.1
37
111
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
33.7
8.1
10
*
L02BA01
ATC
tamoxifen; oral
33.7
8.1
10
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
17.4
8.1
12
7
K92.1
ICD-10 Finland
Melaena
2.7
8.0
52
200
SPAT1125
SPAT
Stoma care and guidance
5.5
7.9
22
41
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.8
7.9
25
54
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
7.9
92
473
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
45.4
7.7
9
*
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
45.4
7.7
9
*
JAH00
NOMESCO Finland
Laparotomy
3.9
7.6
30
80
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.9
7.5
44
158
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.9
7.5
23
48
JLC30
NOMESCO Finland
Pancreatoduodenectomy
80.8
7.4
8
*
L03AA14
ATC
lipegfilgrastim; parenteral
80.8
7.4
8
*
Z51.0
ICD-10 Finland
Radiotherapy session
80.8
7.4
8
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
80.8
7.4
8
*
JFB51
NOMESCO Finland
Other laparoscopic resection of colon
80.8
7.4
8
*
JGB20
NOMESCO Finland
Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis
+∞
7.3
7
*
D01.5
ICD-10 Finland
Carcinoma in situ: Liver, gallbladder and bile ducts
+∞
7.3
7
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
7.3
7
*
JGB36
NOMESCO Finland
Wide excision of rectum
+∞
7.3
7
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
7.3
7
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
7.3
7
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
L02BX02
ATC
degarelix; parenteral
+∞
7.3
7
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
7.3
7
*
8077/2-C21.0
ICD-O-3
Squamous intraepithelial neoplasia, high grade of anus, NOS
+∞
7.3
7
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
7.3
7
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.2
7.3
21
41
JFB43
NOMESCO Finland
Left hemicolectomy
15.9
7.2
11
7
NK6AN
NOMESCO Finland
Total body bone isotope imaging
30.3
7.2
9
*
KC1GB
NOMESCO Finland
Cystography with X-ray
30.3
7.2
9
*
JFA42
NOMESCO Finland
Endoscopic injection in colon
20.2
7.1
10
5
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
4.4
7.1
24
56
WX892
NOMESCO Finland
Monitored bed care
2.2
7.0
68
319
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
7.0
73
356
J01DB01
ATC
cefalexin; oral
1.6
7.0
556
4847
J01MA12
ATC
levofloxacin; systemic
1.8
7.0
136
836
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.9
6.9
40
142
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
8.4
6.8
14
17
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
11.1
6.8
12
11
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
6.8
64
297
C90.0
ICD-10 Finland
Multiple myeloma
40.4
6.8
8
*
HAC20
NOMESCO Finland
Total mastectomy
40.4
6.8
8
*
TJG20
NOMESCO Finland
Transanal irrigation
40.4
6.8
8
*
Z31.5
ICD-10 Finland
Genetic counselling
4.1
6.6
24
60
SPAT1153
SPAT
Removal of sutures
1.6
6.6
224
1605
K83.0
ICD-10 Finland
Cholangitis
6.3
6.5
16
26
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.3
6.4
30
93
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
70.4
6.4
7
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
70.4
6.4
7
*
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.9
6.4
37
132
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
14.4
6.4
10
7
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
14.4
6.4
10
7
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
14.4
6.4
10
7
G04CA02
ATC
tamsulosin; oral
1.6
6.4
199
1391
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
6.4
153
1000
WW500
NOMESCO Finland
Blood transfusion
3.7
6.3
26
73
XKD00
NOMESCO Finland
Uroflowmetry
1.7
6.3
124
765
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.9
6.3
36
127
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
18.2
6.3
9
5
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
+∞
6.3
6
*
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
6.3
6
*
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
+∞
6.3
6
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
6.3
6
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
D01.7
ICD-10 Finland
Carcinoma in situ: Other specified digestive organs
+∞
6.3
6
*
8263/2-C18.4
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of transverse colon
+∞
6.3
6
*
8480/3-C20.9
ICD-O-3
Mucinous adenocarcinoma of rectum, NOS
+∞
6.3
6
*
JGA96
NOMESCO Finland
Other proctotomy or local operation on rectum
+∞
6.3
6
*
SPAT1023
SPAT
Excision of polyp
+∞
6.3
6
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
6.3
6
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
6.3
6
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
6.3
6
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
+∞
6.3
6
*
Y83.2
ICD-10 Finland
Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
26.9
6.2
8
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.0
6.2
23
59
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.0
6.2
33
113
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.7
6.2
40
153
S18
ICPC
Laceration/cut
1.5
6.2
290
2229
P01AB01
ATC
metronidazole; oral, rectal
1.5
6.1
247
1834
N03AX16
ATC
pregabalin; oral
1.6
6.1
161
1079
ZZR00
NOMESCO Finland
Flap of skin
12.6
6.1
10
8
JFB46
NOMESCO Finland
Resection of sigmoid colon
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022145) Colonoscopy Study observation
489
615
17.89
307.65
2.1
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
442
358
25.24
307.65
5.5
1.5
ug/l
18.8
3.7
1.37
375
274
(4035726)
161
193
10.11
128.62
1.4
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
126
128
11.42
113.04
4.2
2.0
u/ml
164.1
106.9
0.17
112
102
(40768804) Tissue Pathology biopsy report
496
1944
4.85
111.48
2.8
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
600
2849
4.98
101.47
5.4
3.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
468
1885
4.39
98.13
3.6
2.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
594
2861
4.77
96.87
7.4
3.7
g/l
34.2
35.4
5.53
571
2619
(3002256) Pathology report gross observation
208
457
5.74
93.55
1.3
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
217
542
5.07
83.52
2.7
1.9
g/l
0.2
0.2
3.10
204
486
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
607
3239
4.24
79.19
10.4
3.9
umol/l
12.6
12.3
0.16
586
3036
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
229
668
4.35
71.49
3.4
2.3
umol/l
8.0
9.4
0.37
203
585
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
362
1464
3.61
70.07
3.4
2.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
260
898
3.76
63.13
2.9
2.5
%
19.0
23.1
4.10
231
763
(3032080) INR in Blood by Coagulation assay
537
2910
3.39
62.25
11.8
10.5
inr
1.3
1.4
0.51
153
806
(3004789) Transferrin [Mass/volume] in Serum or Plasma
268
956
3.66
61.82
2.8
2.4
g/l
2.3
2.3
0.39
256
880
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
191
545
4.25
60.62
2.7
2.0
u/l
39.1
35.2
0.30
163
443
(3022948) Iron [Moles/volume] in Serum or Plasma
279
1065
3.44
57.31
2.9
2.4
umol/l
11.3
13.0
3.27
269
971
(3014576) Chloride [Moles/volume] in Serum or Plasma
241
843
3.62
56.72
10.0
6.1
mmol/l
105.6
104.4
4.21
233
822
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
398
1946
3.01
52.55
4.3
2.7
u/l
39.0
35.3
0.17
381
1851
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
137
359
4.37
48.07
11.2
10.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
375
1853
2.87
47.37
6.1
4.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
712
5008
3.94
46.27
13.0
5.4
u/l
88.3
76.8
4.02
699
4625
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
362
1782
2.83
45.69
2.8
2.2
mg/l
3.4
2.9
1.59
317
1508
(3002582) Erythrocytes [#/volume] in Urine
395
2035
2.79
45.64
3.6
3.0
e6/l
39.9
88.2
0.82
287
1579
(3013826) Glucose [Moles/volume] in Serum or Plasma
621
4065
3.09
44.77
7.5
4.4
mmol/l
7.0
6.9
0.34
599
3806
(3001122) Ferritin [Mass/volume] in Serum or Plasma
463
2639
2.70
43.01
3.6
2.7
ug/l
129.7
142.2
0.54
436
2388
(3030467) Casts [#/volume] in Urine by Automated count
360
1851
2.67
40.61
3.5
2.9
e6/l
0.5
0.5
0.08
253
1399
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
431
2447
2.58
39.22
3.7
3.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
247
1065
2.88
39.07
3.2
2.8
e6/l
1.3
2.0
0.84
128
587
(3018095) Leukocytes [#/volume] in Urine
419
2352
2.58
38.98
4.3
3.5
e6/l
80.9
99.1
0.33
293
1693
(3013650) Neutrophils [#/volume] in Blood by Automated count
548
3501
2.66
38.72
13.3
6.3
e9/l
4.2
4.3
0.45
459
3025
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
528
3349
2.58
37.27
10.1
5.6
mmol/l
1.2
1.2
5.33
459
2828
(3012095) Magnesium [Moles/volume] in Serum or Plasma
228
963
2.88
37.27
4.3
2.6
mmol/l
0.8
0.8
2.11
217
883
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
91
211
4.72
36.97
2.5
2.6
u/ml
0.3
0.4
2.67
42
119
(36304419) Bacteria [Presence] in Urine
341
1784
2.55
36.17
3.4
2.9
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
180
678
3.11
36.02
10.5
7.4
g/l
114.1
122.2
6.11
171
658
(3003694) ABO and Rh group [Type] in Blood
307
1575
2.51
33.42
1.4
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
372
2087
2.42
33.18
3.2
2.2
u/l
59.7
57.6
0.34
346
1903
(3022096) Basophils/100 leukocytes in Blood
460
2837
2.39
33.00
7.4
5.5
%
0.6
0.7
2.42
432
2619
(42870588) Differential panel, method unspecified - Blood
374
2111
2.40
32.81
7.5
5.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
197
819
2.84
32.73
9.8
6.8
mmol/l
0.4
1.3
1.93
164
637
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
247
1153
2.63
32.69
3.0
2.6
e6/l
0.8
1.4
0.96
128
672
(3016502) Oxygen saturation in Arterial blood
183
739
2.89
32.04
10.2
7.0
%
95.3
95.2
0.06
174
711
(3002030) Lymphocytes/100 leukocytes in Blood
471
2979
2.34
31.27
7.7
5.7
%
24.7
26.9
3.73
442
2750
(3027801) Oxygen [Partial pressure] in Arterial blood
193
815
2.78
30.98
10.0
6.8
kpa
13.6
11.5
5.52
184
780
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
193
815
2.78
30.98
10.0
6.8
kpa
5.2
5.1
0.55
185
781
(3006504) Eosinophils/100 leukocytes in Blood
464
2929
2.32
30.77
7.5
5.5
%
2.6
3.0
3.24
435
2702
(3019069) Monocytes/100 leukocytes in Blood
465
2938
2.32
30.77
7.7
5.8
%
8.9
8.8
0.34
437
2724
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
479
3065
2.33
30.76
9.2
5.2
mmol/l
1.2
1.2
3.72
450
2701
(3018010) Neutrophils/100 leukocytes in Blood
464
2953
2.29
29.86
7.4
5.5
%
60.4
57.9
4.11
436
2743
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
45
66
7.15
29.53
4.3
1.8
u/ml
16.8
76.5
1.11
39
57
(3019198) Lymphocytes [#/volume] in Blood
488
3210
2.26
28.47
7.4
5.3
e9/l
2.0
1.8
0.27
422
2807
(3001604) Monocytes [#/volume] in Blood
481
3148
2.25
28.38
7.2
5.3
e9/l
0.6
0.6
0.01
400
2701
(3000991) Gas panel - Venous blood
147
561
2.97
28.29
12.9
7.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
481
3168
2.23
27.67
7.2
5.3
e9/l
0.0
0.0
2.86
399
2722
(40768797) Stomach Pathology biopsy report
203
927
2.57
27.56
1.3
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
361
2123
2.24
27.49
4.7
2.1
mmol/l
2.3
2.4
0.44
321
1738
(3013115) Eosinophils [#/volume] in Blood
489
3270
2.20
26.71
7.6
5.5
e9/l
0.2
0.2
3.75
418
2856
(3027945) Reticulocytes/100 erythrocytes in Blood
192
866
2.58
26.65
2.9
2.2
%
1.9
1.8
0.64
180
763
(3018418) pH of Serum or Plasma
337
1957
2.21
26.17
5.0
3.1
ph
7.4
7.4
0.37
66
326
(3031040) Bacteria [#/volume] in Urine by Automated count
595
4348
2.30
25.51
5.3
4.5
e6/l
2789.5
2609.8
0.02
11
73
(3020779) Urea [Moles/volume] in Serum or Plasma
147
598
2.77
24.95
9.0
6.3
mmol/l
10.3
10.8
0.25
142
564
(3023520) Reticulocytes [#/volume] in Blood
155
652
2.69
24.63
3.4
2.4
e9/l
70.9
67.5
0.50
110
513
(3021589) Normoblasts [#/volume] in Blood
434
2829
2.12
24.58
15.6
8.6
e9/l
0.0
0.0
0.48
339
2312
(3002385) Erythrocyte distribution width [Ratio]
677
5313
2.48
23.26
36.1
16.3
%
14.3
13.7
15.08
669
5178
(3048689) Calprotectin [Mass/mass] in Stool
152
652
2.63
23.13
2.0
2.0
ug/g
244.3
149.4
1.26
128
514
(3026782) Osmolality of Urine
246
1313
2.24
22.99
3.5
2.5
mosm/kgh2o
539.1
551.1
0.42
207
1087
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
95
318
3.24
22.71
1.8
1.7
g/l
1.6
1.5
0.38
87
275
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
117
446
2.89
22.32
1.8
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
775
6592
3.61
21.26
28.3
13.5
mg/l
32.0
25.0
7.25
727
5158
(3042936) Bacteria identified in Isolate by Culture
195
976
2.30
21.03
2.7
2.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
336
2079
2.03
20.96
3.8
3.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
641
5032
2.20
20.08
4.6
4.1
mm/h
16.0
12.7
4.78
603
4591
(3003458) Phosphate [Moles/volume] in Serum or Plasma
178
876
2.31
19.87
6.6
4.7
mmol/l
1.0
1.0
0.33
167
795
(3037467) Urinalysis macro (dipstick) panel - Urine
595
4590
2.04
18.81
5.7
4.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
457
3256
1.90
17.91
4.3
3.7
estimate
0.0
0.0
0.00
96
561
(40768800) Prostate Pathology biopsy report
31
53
6.04
17.55
1.2
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
454
3254
1.87
17.20
6.2
5.0
estimate
0.0
0.0
0.00
103
557
(3009261) Glucose [Presence] in Urine by Test strip
456
3298
1.85
16.53
4.4
3.7
estimate
0.0
0.0
0.50
98
546
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
54
155
3.66
16.34
3.8
1.7
u/ml
52.6
22.9
0.83
54
149
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
735
6280
2.47
16.11
28.5
12.5
ml/min/173m2
74.3
75.5
0.70
615
5055
(3015736) pH of Urine
375
2568
1.84
16.09
3.8
3.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
221
1283
1.98
15.69
4.2
2.2
mmol/l
2.5
2.4
1.81
190
1097
(40758558) Short blood count panel - Blood
243
1470
1.92
15.22
9.4
4.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
525
4032
1.82
14.98
4.4
3.0
u/l
78.7
52.0
3.80
490
3692
(3007164) IgA [Mass/volume] in Serum or Plasma
194
1097
2.00
14.74
1.7
1.3
g/l
2.7
2.8
0.27
102
636
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
140
711
2.17
14.14
4.4
3.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
196
1141
1.94
13.58
1.9
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
425
3125
1.74
13.52
2.4
2.1
pmol/l
92.0
94.9
0.70
259
1599
(3000850) Epithelial cells [#/volume] in Urine
231
1421
1.87
13.51
2.8
2.3
e6/l
4.0
5.6
1.33
198
1229
(3044889) 12 lead EKG panel
602
4897
1.83
13.36
4.8
4.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
20
29
7.04
13.18
1.5
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
210
1271
1.87
12.84
1.2
1.2
u/ml
2.1
1.4
0.48
46
337
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
42
122
3.57
12.50
1.6
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
148
804
2.02
12.41
1.8
1.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
27
58
4.78
11.95
1.0
1.2
—
—
—
0
0
(3036489) Thrombin time
59
217
2.85
11.91
2.3
1.9
s
22.1
21.3
0.63
54
194
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
96
449
2.29
11.78
1.6
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
146
804
1.99
11.75
1.8
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
334
2372
1.68
11.51
3.7
3.0
ng/l
1673.9
1537.7
0.26
306
2023
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
783
7099
2.78
11.48
16.9
9.3
u/l
25.1
26.0
0.94
775
6773
(3020630) Protein [Mass/volume] in Serum or Plasma
114
580
2.12
11.36
2.6
1.6
g/l
64.7
67.1
2.74
105
521
(3005719) IgG [Mass/volume] in Serum or Plasma
92
430
2.28
11.30
3.2
2.0
g/l
11.0
11.0
0.01
84
395
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
50
173
3.01
11.26
1.7
1.5
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
72
303
2.51
11.17
5.3
4.9
%
0.9
0.9
0.35
66
288
(3004809) Band form neutrophils/100 leukocytes in Blood
29
70
4.26
11.15
3.1
3.3
%
0.5
1.7
1.22
24
51
(3017143) Hepatitis C virus Ab [Presence] in Serum
102
508
2.15
10.72
1.6
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
269
1837
1.69
10.55
1.8
1.5
nmol/l
19.5
20.7
0.76
240
1550
(3021879) Hepatitis B virus core Ab [Presence] in Serum
71
307
2.44
10.40
1.5
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
71
307
2.44
10.40
5.2
4.9
%
1.6
1.7
0.31
65
292
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
365
2706
1.62
10.30
2.3
2.2
nmol/l
76.1
78.6
0.89
321
2340
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
431
3337
1.61
10.10
2.4
2.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
99
499
2.12
10.08
3.7
3.9
%
0.8
0.8
0.04
37
116
(3028026) IgM [Mass/volume] in Serum or Plasma
76
344
2.33
10.05
2.7
1.3
g/l
1.6
1.3
0.52
69
319
(3009542) Hematocrit [Volume Fraction] of Blood
669
5798
1.79
9.94
34.4
15.1
%
37.7
39.6
6.24
467
3719
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
102
523
2.08
9.93
5.5
2.6
mmol/l
1.2
1.2
0.15
91
433
(3004588) Protein electrophoresis panel - Serum or Plasma
98
503
2.08
9.50
2.4
1.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
67
295
2.38
9.43
2.1
1.4
g/l
7.3
7.5
0.30
47
217
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
67
295
2.38
9.43
2.1
1.4
g/l
3.9
3.9
0.10
43
212
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
67
295
2.38
9.43
2.1
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
277
2.42
9.36
2.0
1.4
g/l
9.8
10.7
0.67
54
234
(3002032) Base excess in Venous blood by calculation
122
683
1.92
9.26
5.3
3.1
mmol/l
0.9
2.1
2.54
103
548
(40760892) CBC W Ordered Manual Differential panel - Blood
201
1309
1.71
9.23
5.0
4.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
757
6868
2.15
9.23
26.9
13.2
—
—
—
0
0
(4281824)
18
34
5.39
9.19
1.3
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
65
287
2.37
9.10
2.0
1.8
ug/l
1.6
1.7
0.12
58
249
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
58
244
2.48
9.02
2.7
1.3
g/l
0.7
0.5
0.14
47
209
(3037756) Immunofixation for Serum or Plasma
38
128
3.06
8.99
1.5
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
102
545
1.99
8.85
1.5
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
89
453
2.08
8.82
3.5
3.9
%
0.5
0.6
0.12
26
90
(3025159) Blasts/100 leukocytes in Blood
89
454
2.08
8.77
3.7
4.0
%
0.0
0.9
0.48
29
93
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
44
164
2.78
8.70
1.9
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
29
85
3.50
8.56
1.4
1.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
26
71
3.75
8.50
1.3
1.5
pmol/l
170.5
67.3
0.78
26
71
(3021440) Promyelocytes/100 leukocytes in Blood
91
474
2.03
8.47
3.8
4.0
%
0.0
0.1
2.12
33
103
(3007461) Platelets [#/volume] in Blood
789
7323
2.53
8.38
42.9
19.9
e9/l
240.9
242.0
0.16
770
7107
(3026361) Erythrocytes [#/volume] in Blood
789
7325
2.53
8.33
42.9
20.0
e12/l
4.3
4.5
16.63
770
7078
(3010813) Leukocytes [#/volume] in Blood
789
7327
2.52
8.29
42.9
20.0
e9/l
6.9
6.8
0.76
768
7083
(46235355) HIV 1 and 2 tests - Meaningful Use set
116
664
1.87
8.20
1.5
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
54
230
2.44
8.19
5.0
1.4
mg/l
65.5
57.9
0.09
42
183
(3034860) Kappa light chains.free [Mass/volume] in Serum
54
230
2.44
8.19
4.8
1.4
mg/l
184.2
46.7
0.58
42
183
(3037121) Protein [Mass/volume] in Urine
53
224
2.46
8.17
4.7
2.3
g/l
0.5
0.3
0.75
31
69
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
52
218
2.48
8.16
2.2
1.4
g/l
0.0
0.0
0.50
46
199
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
31
98
3.25
8.15
5.8
6.0
iu/ml
810.4
404.1
—
9
14
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
38
136
2.88
8.11
1.2
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
7
17.37
8.09
1.3
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
240
1687
1.59
8.02
4.9
3.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
52
222
2.43
7.85
4.9
1.3
—
1.3
—
0
22
(3030981) Hyaline casts [#/volume] in Urine by Automated count
74
369
2.10
7.74
3.2
2.5
e6/l
0.1
0.2
1.09
74
360
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
686
6113
1.70
7.71
5.2
4.5
mu/l
2.1
2.2
0.21
623
5505
(3045788) Cell count panel - Pleural fluid
22
58
3.87
7.56
1.5
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
272
2.26
7.50
2.2
1.4
g/l
3.2
3.1
0.49
46
214
(3017446) Testosterone [Moles/volume] in Serum or Plasma
83
438
1.99
7.46
1.9
2.3
nmol/l
11.6
15.2
3.16
67
383
(40760888) Immunoglobulin light chains.free panel - Serum
42
166
2.61
7.45
4.5
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
127
771
1.76
7.38
1.6
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
94
521
1.91
7.32
5.6
3.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
226
1597
1.57
7.28
3.3
3.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
54
244
2.30
7.20
3.4
1.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
31
106
3.00
7.18
3.2
2.6
e9/l
4.0
4.7
1.11
31
106
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
75
387
2.03
7.17
2.5
2.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
31
4.91
6.95
2.5
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
197
1362
1.59
6.93
2.6
1.6
mg/l
2.2
1.3
1.06
162
1051
(3003434) Protein [Mass/volume] in Pleural fluid
25
77
3.32
6.87
1.4
1.4
g/l
31.5
27.6
0.70
19
69
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
110
2.89
6.75
3.9
2.8
%
54.6
60.2
1.16
31
110
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
28
94
3.05
6.71
1.1
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
23
69
3.40
6.59
1.5
1.4
e6/l
529.6
2113.1
2.42
12
46
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
51
235
2.25
6.52
2.6
3.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
46
203
2.34
6.49
2.0
1.3
g/l
0.0
0.0
0.00
40
187
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
733
6730
1.76
6.42
5.1
5.0
mmol/l
6.2
6.1
1.19
672
6065
(3047181) Lactate [Moles/volume] in Blood
50
230
2.25
6.42
5.8
6.5
mmol/l
1.4
1.3
0.11
42
205
(36660697) Celiac disease serology panel - Serum
82
454
1.89
6.41
1.2
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
10
15
6.74
6.32
1.8
1.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
22
5.52
6.30
2.9
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
22
5.52
6.30
2.9
2.8
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
46
206
2.31
6.29
2.0
1.3
g/l
0.0
0.0
0.00
40
188
(40768441) Liver Pathology biopsy report
14
30
4.73
6.23
1.4
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
362
2894
1.44
6.19
4.3
4.0
ng/l
30.5
59.1
1.69
278
2166
(3018572) Chloride [Moles/volume] in Blood
39
164
2.45
6.13
6.3
7.2
mmol/l
106.3
105.7
0.37
32
150
(3039000) Anion gap in Blood
39
164
2.45
6.13
6.3
7.2
mmol/l
11.1
11.0
0.11
32
150
(3019309) Folate [Moles/volume] in Red Blood Cells
213
1538
1.52
6.08
1.9
1.8
nmol/l
1165.0
1177.3
0.06
159
1153
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
50
236
2.19
6.04
2.2
1.3
g/l
35.1
37.5
1.64
42
198
(3019060) Gas panel - Arterial blood
86
493
1.83
6.04
5.0
4.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
321
2518
1.45
6.03
5.0
3.9
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
16
6.31
5.96
2.8
1.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
248
1855
1.48
5.95
3.4
2.5
umol/l
5722.3
8014.3
0.28
213
1577
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
203
1464
1.51
5.80
4.1
4.0
ng/l
291.7
390.3
0.39
183
1232
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
56
3.45
5.61
1.8
1.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
83
484
1.79
5.52
6.3
6.9
mmol/l
24.9
24.5
0.60
73
454
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
42
192
2.25
5.50
1.5
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
120
779
1.63
5.41
2.4
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
33
137
2.47
5.35
4.3
3.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
63
3.23
5.34
1.5
1.4
e6/l
25932.8
147972.0
—
9
35
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
75
2.99
5.17
1.6
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
91
564
1.69
4.90
4.6
3.7
ng/l
109.6
92.6
0.88
81
494
(3000570) Elastase.pancreatic [Mass/mass] in Stool
37
169
2.24
4.88
1.2
1.3
ug/g
254.3
294.4
0.50
20
98
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
24
89
2.75
4.88
1.7
1.5
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
10
20
5.05
4.78
2.1
1.7
%
91.8
93.8
—
10
20
(3027456) Digoxin [Moles/volume] in Serum or Plasma
39
186
2.15
4.65
3.1
3.2
nmol/l
0.8
0.8
0.00
31
146
(3045142) Bone marrow Pathology biopsy report
17
53
3.25
4.63
1.6
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
15
43
3.53
4.63
1.3
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
561
4982
1.39
4.60
4.2
3.7
pmol/l
15.1
15.0
0.43
506
4465
(3020682) Albumin/Creatinine [Ratio] in Urine
314
2553
1.37
4.47
4.2
4.0
mg/mmol
13.5
8.5
0.86
216
1644
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
30
4.04
4.45
1.4
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
30
4.04
4.45
1.4
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
30
133
2.30
4.27
1.7
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
16
51
3.18
4.22
1.6
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
216
1665
1.40
4.21
1.8
1.7
pmol/l
444.0
23635435.7
1.52
184
1337
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
32
147
2.22
4.20
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
32
147
2.22
4.20
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
31
141
2.25
4.16
1.9
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
70
423
1.72
4.15
1.6
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
220
1716
1.38
3.97
3.6
2.7
ug/l
0.7
0.7
0.13
155
1170
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
76
2.67
3.92
1.4
1.1
u/ml
1.7
1.9
—
9
24
(3024928) Oxygen saturation in Venous blood
34
165
2.11
3.91
3.2
2.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
28
126
2.26
3.87
1.7
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
362
3059
1.32
3.83
5.5
3.9
ug/l
3.5
2.0
0.82
321
2737
(40767503) Oxygen content in Capillary blood by calculation
31
147
2.15
3.79
3.7
2.5
%
15.6
16.5
0.54
19
73
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
44
3.22
3.79
1.9
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
38
195
1.99
3.78
7.7
4.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
39
3.37
3.77
1.4
1.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
78
2.60
3.74
1.4
1.1
u/ml
2.4
6.2
0.83
11
39
(3012441) Differential panel - Pleural fluid
17
61
2.82
3.70
1.6
1.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
60
361
1.71
3.64
3.8
2.4
%
1.1
1.2
0.21
60
361
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
9
7.83
3.56
1.1
1.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
17
5.34
3.51
1.3
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
6
10.06
3.50
5.7
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
36
3.37
3.48
3.2
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
36
3.37
3.48
3.2
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
27
126
2.18
3.45
4.1
2.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
21
88
2.42
3.41
1.8
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
18
70
2.61
3.40
1.0
1.1
—
—
—
0
0
(4062490)
15
53
2.86
3.37
1.1
1.2
—
—
—
0
0
(4268621)
16
60
2.70
3.24
2.5
2.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
115
832
1.44
3.16
1.4
1.3
titre
516.7
578.5
0.15
24
199
(3034426) Prothrombin time (PT)
9
20
4.54
3.12
1.4
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
223
1802
1.32
3.12
5.0
3.9
estimate
0.0
0.0
0.69
95
540
(3000012) Reticulocyte production index
12
39
3.11
3.10
2.1
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
594
5455
1.31
3.10
38.7
18.1
g/l
329.4
332.5
12.34
594
5418
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
691
6491
1.38
3.07
7.2
6.5
mmol/mol
41.8
40.8
1.76
646
5972
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
35
189
1.89
3.06
1.5
1.6
iu/ml
0.0
0.2
—
6
37
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
12
5.87
3.02
1.9
2.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
287
2412
1.29
2.99
3.2
3.2
mg/l
446.4
178.1
0.52
202
1547
(3025941) Bacteria identified in Stool by Culture
52
320
1.67
2.95
1.4
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
293
2474
1.28
2.93
3.3
3.1
mmol/l
7.6
7.6
0.08
248
2069
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
8
17
4.74
2.92
3.3
1.0
nmol/l
154.0
73.1
—
8
17
(3035285) Chloride [Moles/volume] in Venous blood
22
102
2.19
2.89
4.2
2.3
mmol/l
103.8
105.0
0.55
22
102
(3041354) Potassium [Moles/volume] in Venous blood
22
102
2.19
2.89
4.2
2.3
mmol/l
4.1
4.1
0.09
22
102
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
66
967
0.66
2.79
10.5
7.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
49
303
1.66
2.74
3.3
2.9
pmol/l
4.3
4.5
0.44
43
255
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
65
431
1.55
2.74
5.0
3.5
mmol/l
1.7
1.9
0.19
49
320
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
293
2491
1.27
2.74
4.5
3.8
%
19.6
24.2
7.80
151
1196
(3011648) Oxygen content in Venous blood
15
60
2.53
2.71
1.8
1.9
%
11.3
10.6
0.18
15
60
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
725
6897
1.40
2.70
5.3
5.5
mmol/l
2.5
2.6
4.84
656
6286
(21494890) Protein electrophoresis panel - 24 hour Urine
15
61
2.49
2.63
1.6
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
21
100
2.13
2.60
4.3
2.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
90
646
1.44
2.60
1.5
1.7
%
1.7
1.6
0.54
79
543
(3044007) Cell count panel - Peritoneal fluid
7
15
4.70
2.60
2.6
2.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
22
107
2.08
2.59
3.2
2.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
33
3.06
2.53
1.5
2.5
u/ml
787.0
1325.4
—
10
33
(3042111) Morphology [Interpretation] in Bone marrow Narrative
21
102
2.09
2.49
2.0
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
22
109
2.05
2.48
2.6
2.3
—
—
—
0
0
(3009343) pH of Capillary blood
66
450
1.51
2.47
5.0
3.5
ph
7.4
7.4
—
10
55
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
138
1.91
2.43
1.3
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
78
553
1.45
2.41
2.2
1.8
nmol/l
365.3
358.3
0.12
73
496
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
12
5.03
2.40
2.3
3.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
19
91
2.11
2.34
1.1
1.2
u/ml
430.2
268.1
1.07
12
49
(3006184) Hemoglobin [Mass/volume] in Capillary blood
29
162
1.82
2.34
3.0
2.1
g/l
127.1
133.8
0.75
23
119
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
20
98
2.07
2.33
1.3
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
28
3.24
2.31
1.7
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
28
3.24
2.31
1.7
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
10
35
2.88
2.31
1.2
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
18
3.91
2.25
1.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
29
3.13
2.23
3.4
2.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
29
165
1.78
2.21
1.5
1.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
53
354
1.53
2.20
7.4
3.2
%
42.6
47.7
0.89
53
348
(3013512) EKG study
255
2180
1.24
2.19
4.8
4.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
15
67
2.26
2.18
1.3
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
19
3.71
2.15
1.7
1.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
94
706
1.37
2.13
3.2
3.1
ng/l
268.4
221.6
0.47
87
660
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
110
1.93
2.07
1.3
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
89
2.05
2.07
1.3
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
19
96
2.00
2.06
1.1
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
19
96
2.00
2.06
1.1
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
20
3.52
2.06
1.6
1.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
42
271
1.58
2.04
4.2
3.7
mmol/l
1.4
1.5
0.16
42
266
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
90
2.02
2.01
1.3
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
49
330
1.52
1.98
1.1
1.2
iu/ml
130.2
133.3
0.02
19
124
(3000330) Specific gravity of Urine by Test strip
56
389
1.47
1.96
6.1
3.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
39
251
1.58
1.93
1.0
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
15
71
2.13
1.93
1.3
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
24
135
1.80
1.93
1.7
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
39
2.58
1.92
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
78
2.07
1.92
1.3
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
58
2.26
1.91
2.2
3.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
128
1.82
1.91
1.3
1.7
iu/l
2.1
4.6
—
8
44
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
22
3.20
1.88
1.4
1.1
umol/l
27.3
30.1
—
7
22
(3052851) Hemolysis interference index of Serum or Plasma
32
198
1.64
1.86
4.7
3.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
17
86
2.00
1.86
1.1
1.0
g/l
1.5
1.5
0.13
17
74
(3016750) Collection duration of Urine
11
46
2.41
1.85
3.1
2.3
min
541.2
494.9
—
5
34
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
19
101
1.90
1.82
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
22
124
1.80
1.77
1.6
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
124
1.80
1.77
1.1
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
13
3.86
1.71
1.2
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
13
3.86
1.71
1.0
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
42
2.40
1.68
1.7
2.9
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
42
2.40
1.68
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
39
261
1.52
1.66
1.3
1.2
—
—
—
0
0
(4306422)
16
83
1.95
1.65
1.3
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
14
69
2.05
1.65
3.1
2.5
ml
675.6
607.2
—
5
45
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
221
1916
1.21
1.62
1.6
1.6
mmol/l
1.4
1.4
0.02
184
1576
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
207
1.57
1.59
1.7
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
26
2.71
1.58
1.0
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
122
1.74
1.55
1.2
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
700
6736
1.25
1.55
4.6
4.8
mmol/l
4.4
4.5
3.50
646
6156
(3005570) Glucose [Moles/volume] in Urine
15
78
1.94
1.55
1.9
1.9
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
14
71
1.99
1.54
1.0
1.1
nmol/l
265.3
391.3
—
7
60
(3017817) Protein [Mass] in Urine collected for unspecified duration
14
71
1.99
1.54
1.6
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
33
2.44
1.54
2.9
1.8
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
15
3.35
1.52
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
73
941
0.75
1.52
4.5
5.0
%
32.8
32.7
0.04
50
625
(44790049)
13
65
2.02
1.49
1.5
1.6
—
—
—
0
0
(44790047)
13
65
2.02
1.49
1.5
1.6
—
—
—
0
0
(44790048)
13
65
2.02
1.49
1.5
1.6
—
—
—
0
0
(44806118)
13
65
2.02
1.49
1.5
1.6
—
—
—
0
0
(3000492) Spirometry study
70
534
1.34
1.49
1.7
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
693
6670
1.23
1.48
4.5
4.8
mmol/l
1.4
1.4
0.50
629
6053
(44813793)
9
38
2.38
1.46
1.3
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
59
2.05
1.44
1.7
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
22
2.74
1.43
2.0
2.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
16
88
1.83
1.42
1.3
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
17
96
1.79
1.39
1.7
1.2
u/l
9.9
7.4
0.30
11
80
(3022217) INR in Platelet poor plasma by Coagulation assay
128
1068
1.23
1.37
25.3
29.3
inr
1.6
1.4
0.64
15
148
(3042631) Mycobacterium sp identified in Specimen
15
82
1.84
1.36
2.2
2.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
669
6432
1.21
1.35
4.1
4.3
mmol/l
1.3
1.3
0.73
606
5791
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
38
0.00
1.34
0.0
1.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
10
47
2.14
1.34
2.6
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
61
1.98
1.33
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
61
1.98
1.33
3.1
2.8
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
24
2.51
1.30
1.5
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
24
2.51
1.30
1.5
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
46
336
1.39
1.30
5.3
3.5
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
18
2.79
1.28
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
18
2.79
1.28
3.8
2.4
—
—
—
0
0
(3017704) Immunofixation for Urine
9
44
2.06
1.27
1.1
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
260
2336
1.16
1.24
2.1
2.2
u/l
136.7
271.9
2.15
239
2186
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
29
196
1.50
1.23
1.3
1.5
g/l
0.3
0.2
1.70
29
191
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
56
1.98
1.22
1.3
1.1
u/ml
0.5
0.9
—
6
24
(3024471) HLA-A [Type]
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
37
2.17
1.21
1.0
1.0
—
—
—
0
0
(3020891) Body temperature
41
300
1.39
1.17
5.9
4.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
50
2.01
1.17
2.2
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
36
258
1.41
1.15
2.2
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
24
159
1.52
1.13
1.8
1.6
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
30
2.34
1.12
1.1
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
31
2.27
1.10
1.0
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
27
185
1.47
1.09
1.6
1.6
e6/l
36422.9
13165.6
0.41
19
134
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
21
2.39
1.09
3.2
4.4
—
—
—
0
0
(4024509)
11
60
1.84
1.03
1.7
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
99
1.63
1.00
1.3
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
37
275
1.36
0.99
2.4
1.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
49
1.85
0.99
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
49
1.85
0.99
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
49
1.85
0.99
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
50
1.81
0.97
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
50
1.81
0.97
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
50
1.81
0.97
1.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
31
0.00
0.96
0.0
1.2
—
6.8
—
0
31
(3013139) Helicobacter pylori Ag [Presence] in Stool
54
427
1.28
0.95
1.3
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
77
1.70
0.95
4.8
3.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
27
2.23
0.93
1.2
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
27
2.23
0.93
1.2
1.8
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
10
55
1.83
0.92
2.3
1.9
u/field
1.6
1.4
—
5
21
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
72
593
1.23
0.91
1.5
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
63
1.76
0.90
2.5
2.2
—
—
—
0
0
(4034850)
18
261
0.68
0.83
14.5
10.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
46
1.75
0.82
1.1
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
46
1.75
0.82
1.1
1.6
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
11
65
1.70
0.82
1.4
1.2
nmol/l
1.3
1.5
0.21
11
52
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
58
705
0.81
0.82
1.6
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
235
2157
1.12
0.80
3.5
3.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
33
1.82
0.79
1.0
1.3
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
6
33
1.82
0.79
1.0
1.2
u/l
8.8
18.9
—
6
22
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
6
33
1.82
0.79
1.0
1.2
u/l
54.3
75.1
—
6
22
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
48
1.67
0.79
2.3
2.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
38
296
1.30
0.78
1.8
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
27
0.00
0.77
0.0
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
59
1.70
0.76
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
14
91
1.55
0.75
1.3
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
24
2.09
0.74
2.2
1.9
ug/l
43.2
53.2
—
5
24
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
38
1.85
0.73
1.0
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
38
1.85
0.73
2.1
2.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
68
1.63
0.72
1.1
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
57
1.59
0.71
1.7
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
85
1.54
0.69
1.2
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
27
1.86
0.68
1.2
1.3
u/l
173.6
203.1
—
5
27
(3035637) Corticotropin [Mass/volume] in Plasma
7
42
1.67
0.68
1.6
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
91
0.55
0.67
1.2
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
43
1.63
0.67
24.1
13.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
26
197
1.33
0.66
1.2
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
145
1.39
0.66
1.7
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(44806420)
5
30
1.67
0.61
3.0
2.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
210
0.71
0.61
1.9
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
23
174
1.33
0.60
2.1
1.8
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
192
1.31
0.60
1.2
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
22
0.00
0.59
0.0
2.5
—
8.7
—
0
13
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
53
1.51
0.58
1.5
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
275
0.76
0.57
1.2
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
83
730
1.15
0.57
1.3
1.4
—
—
—
0
0
(4211845)
6
36
1.67
0.56
3.2
2.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
194
1.30
0.56
1.2
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
37
1.63
0.55
1.5
5.3
%
13.1
13.4
—
6
37
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
62
1.46
0.53
1.7
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
55
471
1.18
0.53
3.2
2.9
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
63
1.43
0.52
1.4
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
48
408
1.19
0.51
3.0
3.0
e9/l
5.1
4.1
1.42
37
292
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
41
1.47
0.50
1.5
1.4
g/l
1.3
1.0
—
6
41
(3005322) IgE [Units/volume] in Serum or Plasma
43
363
1.19
0.49
1.3
1.2
u/ml
433.9
220.0
0.34
36
331
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
117
1066
1.11
0.48
1.3
1.3
iu/ml
19.7
39.1
3.29
38
323
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
33
396
0.83
0.46
1.6
1.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
117
0.68
0.46
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
28
229
1.23
0.44
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
266
1.21
0.44
1.3
1.2
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
31
1.62
0.43
2.0
2.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
31
1.62
0.43
2.2
1.7
umol/l
20.3
3.8
—
5
19
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
18
140
1.29
0.42
1.2
1.2
u/l
147.5
21.1
0.76
18
122
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
67
751
0.88
0.42
2.2
2.5
ug/l
6.7
7.3
0.09
58
657
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
58
1.38
0.41
1.0
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
45
389
1.17
0.41
1.2
1.4
—
48.3
—
0
18
(3006462) Nitrate [Presence] in Urine
5
33
1.52
0.41
3.4
3.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
109.9
—
0
16
(3024869) Neuronal Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
13
97
1.35
0.39
1.2
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
57
640
0.88
0.38
3.6
3.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
164
1540
1.08
0.37
4.3
4.0
kg/l
1.0
1.0
0.55
25
225
(3019832) Treponema pallidum Ab [Presence] in Serum
20
246
0.81
0.37
1.6
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
14
180
0.77
0.37
1.0
1.2
—
2.7
—
0
19
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
20
162
1.24
0.35
2.3
2.0
mg/l
12.8
12.2
0.15
20
150
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
44
1.37
0.34
2.8
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
25
210
1.20
0.33
1.4
1.4
—
—
—
0
0
(4094501)
24
201
1.20
0.32
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
74
1.36
0.32
1.9
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
110
1025
1.08
0.31
1.3
1.3
u/ml
24.2
13.8
0.43
35
381
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
52
1.35
0.31
1.3
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
52
1.35
0.31
1.3
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
52
1.35
0.31
1.3
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
75
1.34
0.30
1.9
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
84
1.31
0.30
1.3
1.2
nmol/l
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
22
259
0.85
0.28
1.7
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
76
1.32
0.28
1.9
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
76
1.32
0.28
1.9
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
131
1.23
0.27
1.6
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
150
0.80
0.27
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
31
352
0.88
0.26
1.3
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
18
214
0.84
0.26
1.3
1.6
mg/l
6.2
6.0
0.01
13
159
(3014051) Protein [Presence] in Urine by Test strip
14
171
0.82
0.26
1.8
2.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
77
1.30
0.26
1.9
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
25
288
0.86
0.26
1.4
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
25
216
1.16
0.25
3.0
2.4
ug/min
110.0
78.3
—
8
134
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
77
1.17
0.24
2.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
81
0.74
0.24
1.0
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
40
1.25
0.22
1.2
1.5
—
—
—
0
0
(3019225) pH of Specimen
74
692
1.08
0.21
5.3
3.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
3.8
—
0
13
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
16
136
1.18
0.20
1.3
2.0
pmol/l
198.8
217.0
0.37
16
127
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
49
1.23
0.20
1.3
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
6
52
1.15
0.19
1.0
1.5
—
64.0
—
0
5
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
6
53
1.13
0.18
1.0
1.0
mg/l
279.3
286.0
—
6
48
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
6
53
1.13
0.18
1.0
1.5
—
271.2
—
0
8
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
61
1.15
0.17
1.4
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
26
288
0.90
0.17
1.7
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
57
537
1.07
0.15
3.8
2.4
ml/min/173m2
57.7
61.4
0.38
30
218
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
98
0.81
0.13
1.6
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
123
1.14
0.12
1.0
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
17
152
1.12
0.12
1.5
1.2
e6/l
2.1
61.7
0.93
11
124
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
17
152
1.12
0.12
1.6
1.3
e6/l
172.8
1001.2
0.61
11
127
(3028707) Methadone [Presence] in Urine by Screen method
5
48
1.04
0.09
1.4
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
54
1.11
0.09
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
65
0.77
0.08
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
98
1.12
0.07
2.1
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
71
0.84
0.07
1.3
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
75
1.07
0.07
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
90
0.89
0.06
1.4
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
90
0.89
0.06
1.3
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
93
0.86
0.06
1.3
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
93
0.86
0.06
1.3
1.2
—
—
—
0
0
(4010399)
55
533
1.03
0.06
1.5
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
119
1.09
0.06
1.2
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
16
149
1.08
0.05
1.4
1.7
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
19
182
1.04
0.02
1.5
1.8
nmol/l
43.2
43.6
0.03
19
169
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
144
1.04
0.00
1.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
50
1.00
0.00
1.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
75
0.93
0.00
1.1
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
140
1.00
0.00
1.2
1.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
78
0.90
0.00
1.0
1.1
—
21.5
—
0
5
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
84
0.95
0.00
1.5
1.7
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
86
0.93
0.00
1.3
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_DIGESTIVE_EXALLC – Carcinoma in situ of other and unspecified digestive organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).